<DOC>
	<DOCNO>NCT01205282</DOCNO>
	<brief_summary>The investigator propose pilot , single blind , placebo run-in , dose find study pioglitazone child autism ultimate goal identify appropriate dose outcome measure large follow-up randomize placebo control clinical trial . The specific aim study : 1 ) To examine safety pioglitazone child autism spectrum disorder ( ASD ) age 5-12 year ; 2 ) To identify appropriate outcome measure use follow-up multisite randomize control trial pioglitazone child ASD ; 3 ) To determine maximum tolerate dose use follow-up multisite randomize controlled trial ; 4 ) To examine effect pioglitazone marker inflammation ( cytokine level ) oxidative stress ( superoxide dismutase , malonyl aldehyde ) ; 5 ) To explore relationship different dos response treatment .</brief_summary>
	<brief_title>Dose Finding Study Pioglitazone Children With Autism Spectrum Disorders ( ASD ) ( PIO )</brief_title>
	<detailed_description />
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>1 . Male female outpatient 512 year age inclusive ( see Note ) . 2 . Meet Diagnostic Statistical Manual Mental Disorders , 4th Edition , Text Revision ( DSMIV ) criterion . DSMIV criterion Autistic Disorder Asperger 's Disorder ( autism spectrum disorder ) confirm clinician expertise individual ASD . Best estimate Diagnosis reach use DSMIV criterion , Autism Diagnostic Observation Schedule ( ADOSG ) Autism Diagnostic InterviewRevised ( ADIR ) . 3 . Have Clinical Global ImpressionSeverity ( CGIS ) score â‰¥ 4 ( moderately ill ) Baseline . 4 . If already receive stable nonpharmacologic educational , behavioural , and/or dietary intervention , continuous participation precede 3 month prior Screening electively initiate new modify ongoing intervention duration study . 5 . Have normal physical examination laboratory test result Screening . If abnormal , find ( ) must deem clinically insignificant Investigator . 1 . Patients born prior 35 week gestational age . 2 . Families without sufficient command English Language . 3 . Patients primary psychiatric diagnosis autism Screening . 4 . Patients current neurological disease , include , limited , movement disorder , tuberous sclerosis , fragile X , know genetic syndrome . 5 . Pregnant female patient , female patient sexually active , female patient use birth control pill whatever reason . 6 . Patients medical condition might interfere conduct study , confound interpretation study result , endanger wellbeing . Patients evidence history malignancy significant hematological , endocrine , cardiovascular ( include rhythm disorder ) , respiratory , renal , hepatic , gastrointestinal disease . Patients stable epilepsy ( seizures 6 month ) stable dos antiepileptic medication ( change 3 month ) allow study . 7 . Patients take psychoactive medication ( ) . 8 . Patients take insulin . 9 . Patients unable tolerate venipuncture procedure blood sample . 10 . Patients parent ( ) /caregiver ( ) smoke . 11 . Patients previous bladder infection ( ) . 12 . Patients family history bladder cancer .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>ASD</keyword>
</DOC>